L W Kwak Selected Research

L W Kwak Research Topics

13	Neoplasms (Cancer) 02/2014 - 05/2000
8	Lymphoma (Lymphomas) 12/2014 - 05/2000
4	Multiple Myeloma 09/2012 - 07/2001
2	B-Cell Lymphoma (Lymphoma, B Cell) 12/2014 - 04/2009
2	Residual Neoplasm 05/2002 - 09/2000
2	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 07/2001 - 09/2000
1	Hodgkin Disease (Hodgkin's Disease) 01/2018
1	Osteolysis 09/2012
1	Tumor Lysis Syndrome 06/2012
1	Methemoglobinemia 06/2012
1	Glucosephosphate Dehydrogenase Deficiency 06/2012
1	Hemolysis 06/2012
1	Hyperuricemia 06/2012
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2008
1	Testicular Neoplasms (Testicular Cancer) 05/2002
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 02/2000

6	AntigensIBA 04/2011 - 05/2000
4	VaccinesIBA 02/2014 - 09/2000
4	Immunoglobulins (Immunoglobulin)IBA 08/2005 - 10/2000
3	DNA (Deoxyribonucleic Acid)IBA 02/2014 - 09/2000
2	Proteins (Proteins, Gene)FDA Link 04/2011 - 10/2000
2	Rituximab (Mabthera)FDA Link 04/2009 - 01/2008
2	Neoplasm Antigens (Tumor Antigens)IBA 08/2005 - 05/2000
2	EpitopesIBA 08/2005 - 10/2000
2	DefensinsIBA 12/2001 - 05/2000
2	CytokinesIBA 10/2001 - 10/2000
2	Immunoglobulin Idiotypes (Idiotype, Immunoglobulin)IBA 07/2001 - 05/2000
1	Brentuximab VedotinIBA 01/2018
1	Long Noncoding RNAIBA 12/2014
1	ibrutinibIBA 12/2014
1	Lenalidomide (CC 5013)FDA Link 02/2014
1	p38 Mitogen-Activated Protein KinasesIBA 09/2012
1	rasburicase (Elitek)FDA Link 06/2012
1	ibritumomab tiuxetan (Zevalin)FDA Link 04/2009
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2008
1	Bortezomib (Velcade)FDA Link 01/2008
1	Telomerase (Telomerase Reverse Transcriptase)IBA 05/2002
1	ChemokinesIBA 12/2001
1	Chemokine CCL21IBA 12/2001
1	Chemokine CXCL12IBA 12/2001
1	beta-DefensinsIBA 12/2001
1	Cancer VaccinesIBA 03/2001
1	Peptides (Polypeptides)IBA 10/2000
1	Monoclonal AntibodiesIBA 10/2000
1	Biomarkers (Surrogate Marker)IBA 09/2000
1	Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA 09/2000
1	Sepharose (Agarose)IBA 09/2000
1	Chlorinated HydrocarbonsIBA 02/2000